Rp-8-CPT-cAMPS sodium is a cAMP analog that acts as a potent and competitive antagonist of cAMP-induced activation of cAMP-dependent protein kinases PKAI and PKAII; it preferentially binds to site A of RI over site B of RII. It blocks VASP phosphorylation induced by 6-Bnz-cAMP and significantly reduces VASP phosphorylation stimulated by forskolin and fenoterol; it decreases GTP-loading of Rap1 induced by both 8-pCPT-2'-O-Me-cAMP and 6-Bnz-cAMP; it markedly attenuates the enhancement of bradykinin-induced IL-8 release by the PKA activator 6-Bnz-cAMP and the Epac activator 8-pCPT-2'-O-Me-cAMP; it inhibits both endothelium-dependent and -independent relaxation induced by Venomin in pre-contracted rat mesenteric artery rings.